RHY Share Price Performance
AU$0.10
0.06 (118.75%)
Price AU$0.10
Share PriceAU$0.10
RHY Community Narratives
There are no narratives available yet.
Recent RHY News & Updates
No updates
Rhythm Biosciences Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0077
- Gross Margin
- 126.84%
- Net Profit Margin
- -68.73%
- Debt/Equity Ratio
- 0%
Rhythm Biosciences Limited Competitors
About RHY
- Founded
- 2017
- Employees
- n/a
- CEO
- WebsiteView website
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.
Australian Market Performance
- 7 Days: 1.2%
- 3 Months: 7.7%
- 1 Year: 15.0%
- Year to Date: 7.3%
The market is up 1.2% over the last week, with the Materials sector leading the way, up 4.0%. In the last year, the market has climbed 15%. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading